Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium
- PMID: 17149689
- DOI: 10.14670/HH-22.169
Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium
Abstract
Objective: The endometrium expresses estrogen (ER) and progesterone receptor (PR), which are related to autocrine and paracrine processes that respond to estrogen and progesterone. Therefore, the aim of this study was to evaluate the distribution pattern of ERalpha, ERbeta, PR-A and PR-B with monoclonal antibodies in normal human endometrial tissue.
Study design: Human endometrial tissue was obtained from 84 premenopausal and 11 postmenopausal patients and immunohistochemically analysed with monoclonal antibodies against ERalpha, ERbeta, PR-A and PR-B.
Results: ERalpha, PR-A and PR-B declined significantly (p<0.001, p<0.05, p<0.05 respectively) in glandular epithelium from proliferative to late secretory phase. The ERbeta immunohistochemical reaction showed a similar significant declining pattern (p<0.05), although the staining intensity was lower than that of ERalpha. While ERalpha, ERbeta and PR-B decrease significantly in atrophic endometrial tissue compared to proliferative endometrium, a significant up-regulation of PR-A was observed compared to late secretory phase (p<0.05).
Conclusion: ERalpha, ERbeta, PR-A and PR-B were expressed in normal human endometrium with a cyclical variation during the menstrual cycle. In normal postmenopausal endometrial tissue, a down-regulation of ERalpha, ERbeta and PR-B occurs with a subsequent higher expression of PR-A. These results show the presence of steroid receptors in human epithelium, indicating that these cells respond to estrogen and progesterone, thus playing a significant role in endometrial physiology.
Similar articles
-
Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).Anticancer Res. 2005 May-Jun;25(3A):1679-86. Anticancer Res. 2005. PMID: 16033082
-
Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium.Acta Histochem. 2004;106(3):245-52. doi: 10.1016/j.acthis.2004.02.005. Acta Histochem. 2004. PMID: 15186931
-
Quantitative histomorphometric analysis of gonadal steroid receptor distribution in the normal human endometrium through the menstrual cycle.Histochem Cell Biol. 2005 Jun;123(4-5):463-74. doi: 10.1007/s00418-004-0748-z. Epub 2005 May 12. Histochem Cell Biol. 2005. PMID: 15889268
-
Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium.Acta Histochem. 2009;111(4):349-59. doi: 10.1016/j.acthis.2008.11.012. Epub 2009 Feb 4. Acta Histochem. 2009. PMID: 19195687 Review.
-
Estrogen receptor β: the guardian of the endometrium.Hum Reprod Update. 2015 Mar-Apr;21(2):174-93. doi: 10.1093/humupd/dmu053. Epub 2014 Oct 10. Hum Reprod Update. 2015. PMID: 25305176 Review.
Cited by
-
The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes.Stem Cell Res Ther. 2010 Sep 13;1(4):28. doi: 10.1186/scrt28. Stem Cell Res Ther. 2010. PMID: 20836886 Free PMC article.
-
Influence of AKT on progesterone action in endometrial diseases.Biol Reprod. 2014 Sep;91(3):63. doi: 10.1095/biolreprod.114.119255. Epub 2014 Aug 6. Biol Reprod. 2014. PMID: 25100707 Free PMC article. Review.
-
MSX1-expression during the different phases in healthy human endometrium.Arch Gynecol Obstet. 2023 Jul;308(1):273-279. doi: 10.1007/s00404-023-07033-5. Epub 2023 Apr 27. Arch Gynecol Obstet. 2023. PMID: 37101223 Free PMC article.
-
Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):37-45. doi: 10.1007/s00259-010-1589-8. Epub 2010 Aug 18. Eur J Nucl Med Mol Imaging. 2011. PMID: 20717823 Clinical Trial.
-
Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.J Clin Endocrinol Metab. 2012 Jul;97(7):E1316-26. doi: 10.1210/jc.2012-1018. Epub 2012 Apr 6. J Clin Endocrinol Metab. 2012. PMID: 22492871 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials